InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2024-08-05 00:00:00 ET · period of report 2024-08-01 · accession 0001628280-24-034804 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-08-05 2024-08-01 TDOC Raman-Tangella Vidya Chief MEDICAL Off M - OptEx — +10.2K 37.5K +38% —
D 2024-08-05 2024-08-02 TDOC Raman-Tangella Vidya Chief MEDICAL Off S - Sale+OE $8.14 -3,857 33.7K -10% -$31.4K
D 2024-08-05 2024-08-01 TDOC Raman-Tangella Vidya Chief MEDICAL Off M - OptEx $0.00 -10.2K 30.7K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-08-01 M A 10,244 — 37,524 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2024-08-02 S D 3,857 $8.14 33,667 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3 Derivative Restricted Stock Units 2024-08-01 M D 10,244 $0.00 30,732 D — · — to — 10,244 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On May 1, 2022, the reporting person was granted 122,927 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.